Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo

Mutagenesis

Volumn 28, Issue 2, 2013, Pages 181-185

  Schults, Marten A ^a   Chiu, Roland K ^a,c   Nagle, Peter W ^a,c   Wilms, Lonneke C ^b   Kleinjans, Jos C ^b   Van Schooten, Frederik J ^a   Godschalk, Roger W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CATALASE; CYTOCHROME P450 1B1;

ADULT; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLISM; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CARCINOGENS; CARCINOGENS, ENVIRONMENTAL; CATALASE; CELL LINE, TUMOR; COMET ASSAY; DNA ADDUCTS; DNA REPAIR; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LINEAR MODELS; LUNG; LYMPHOCYTES; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 84874297925     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges070     Document Type: Article

References (25)

1. Phillips, D.H. (2005) DNA adducts as markers of exposure and risk. Mutat. Res., 577, 284-292
2. Eder, E. (1999) Intraindividual variations of DNA adduct levels in humans. Mutat. Res., 424, 249-261
3. Rojas, M., Cascorbi, I., Alexandrov, K., Kriek, E., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I.and Bartsch, H. (2000) Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis, 21, 35-41
4. Palli, D., Masala, G., Vineis, P., et al. (2003) Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults. Carcinogenesis, 24, 739-746
5. Besaratinia, A., Besarati Nia, A., Kleinjans, J.C. and Van Schooten, F.J. (2002) Biomonitoring of tobacco smoke carcinogenicity by dosimetry of DNA adducts and genotyping and phenotyping of biotransformational enzymes: A review on polycyclic aromatic hydrocarbons. Biomarkers, 7, 209-229
6. Zhao, H., Wang, L.E., Li, D., Chamberlain, R.M., Sturgis, E.M. and Wei, Q. (2008) Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: A genotype-phenotype correlation analysis. Carcinogenesis, 29, 1560-1566
7. Rojas, M., Godschalk, R., Alexandrov, K., Cascorbi, I., Kriek, E., Ostertag, J., Van Schooten, F.J. and Bartsch, H. (2001) MyeloperoxidaseY463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients. Carcinogenesis, 22, 1015-1018
8. Ketelslegers, H.B., Gottschalk, R.W., Godschalk, R.W., Knaapen, A.M., van Schooten, F.J., Vlietinck, R.F., Kleinjans, J.C. and van Delft, J.H. (2006) Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol. Biomarkers Prev., 15, 624-629
9. Li, D., Wang, M., Cheng, L., Spitz, M.R., Hittelman, W.N. and Wei, Q. (1996) In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res., 56, 3638-3641
10. Wilms, L.C., Boots, A.W., de Boer, V.C., et al. (2007) Impact of multiple genetic polymorphisms on effects of a 4-week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in human volunteers. Carcinogenesis, 28, 1800-1806
11. Knaapen, A.M., Ketelslegers, H.B., Gottschalk, R.W., et al. (2004) Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension. Clin. Chem., 50, 1664-1668
12. Reddy, M.V. and Randerath, K. (1986) Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551
13. Godschalk, R.W., Maas, L.M., Van Zandwijk, N., van t Veer, L.J., Breedijk, A., Borm, P.J., Verhaert, J., Kleinjans, J.C. and van Schooten, F.J. (1998) Differences in aromatic-DNA adduct levels between alveolar macrophages and subpopulations of white blood cells from smokers. Carcinogenesis, 19, 819-825
14. Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G.H., Agoston, E.S., Yamamoto, M.and Kensler, T.W. (2007) NRF2 modulates aryl hydrocarbon receptor signaling: Influence on adipogenesis. Mol. Cell. Biol., 27, 7188-7197
15. Godschalk, R.W., Dallinga, J.W., Wikman, H., Risch, A., Kleinjans, J.C., Bartsch, H.and Van Schooten, F.J. (2001) Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2. Pharmacogenetics, 11, 389-398
16. Ashton, K.A., Proietto, A., Otton, G., Symonds, I., McEvoy, M., Attia, J., Gilbert, M., Hamann, U.and Scott, R.J. (2010) Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol., 34, 328-337
17. Beuten, J., Gelfond, J.A., Byrne, J.J., Balic, I., Crandall, A.C., Johnson-Pais, T.L., Thompson, I.M., Price, D.K. and Leach, R.J. (2008) CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. Carcinogenesis, 29, 1751-1757
18. Bandiera, S.Weidlich, S., Harth, V., Broede, P., Ko, Y.and Friedberg, T. (2005) Proteasomal degradation of human CYP1B1: Effect of the Asn453Ser polymorphism on the post-Translational regulation of CYP1B1 expression. Mol. Pharmacol., 67, 435-443
19. Sissung, T.M., Price, D.K., Sparreboom, A.and Figg, W.D. (2006) Pharmacogenetics and regulation of human cytochrome P450 1B1: Implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol. Cancer Res., 4, 135-150
20. Forsberg, L., Lyrenäs, L., de Faire, U.and Morgenstern, R. (2001) A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic. Biol. Med., 30, 500-505
21. Barouki, R.and Morel, Y. (2001) Repression of cytochrome P450 1A1 gene expression by oxidative stress: Mechanisms and biological implications. Biochem. Pharmacol., 61, 511-516
22. Morel, Y.and Barouki, R. (1998) Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J.Biol. Chem., 273, 26969-26976
23. Barker, C.W., Fagan, J.B. and Pasco, D.S. (1994) Down-regulation of P4501A1 and P4501A2 mRNA expression in isolated hepatocytes by oxidative stress. J.Biol. Chem., 269, 3985-3990
24. Reyes, H., Reisz-Porszasz, S.and Hankinson, O. (1992) Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science, 256, 1193-1195
25. Itoh, K., Chiba, T., Takahashi, S., et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 236, 313-322